Skip to content

Clinical trials

Proteinuria trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Proteinuria Country / region: Canada Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20071
20091
20112
20121
20133
20151
20172
20183
20201
20212
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting4
Terminated3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Novartis Pharmaceuticals3
Bayer2
AbbVie (prior sponsor, Abbott)1
Alexion Pharmaceuticals, Inc.1
Calliditas Therapeutics AB1
Chiesi Farmaceutici S.p.A.1
GlaxoSmithKline1
Hiddo Lambers Heerspink1
Kirby Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Proteinuria25
Renal Insufficiency, Chronic8
Glomerulonephritis, IGA5
Diabetes Mellitus3
Diabetes Mellitus, Type 22
Diabetic Nephropathies2
Glomerulonephritis, Membranous2
Glomerulosclerosis, Focal Segmental2
Hyperlipidemias2
Kidney Diseases2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.